Merve Karacaoglu, MSc
Merve's research within the Vici project focuses on identifying patients at risk of developing unidentified somatic symptoms, such as pain, itch or fatigue. She is interested in unravelling the risk factors associated with early stage symptoms, and she tries to understand how and why certain patient groups acquire chronic somatic symptoms over time. These symptoms can have lifelong debilitating effects for the patients, thereby highly impacting their daily functioning and quality of life.
Having more scientific insight on the underlying mechanisms has direct societal implications such as early detection of somatic symptoms in primary care as well as reduced costs of healthcare utilization, not to mention a better quality of life of patients receiving early interventions. Her research aims to address this problem by making use of psychological, neurobiological and genetic methods.Back to the people page
News and events
Scientists present NeuroLabNL research agenda to ministers What effect does bullying have on the brain? This is just one of the key research questions included in the NeuroLabNL science agenda. Scientists presented the agenda to Ministers Van Engelshoven and Dekker on 3 July at Campus The Hague.
First guidelines for applying placebo effect in clinical practice It is becoming increasingly clear that the placebo effect has a great influence on medical treatment. An international, interdisciplinary team of researchers has now written a first set of guidelines on how to apply the placebo effect in clinical practice
Symposium 'Clinical Implications of Placebo Effects' On 21 June, 2018 a symposium about clinical implications of placebo effects will be held in Museum Boerhaave, Leiden.
With Regine Klinger, Luana Colloca, and Andrea Evers as speakers
Dissertation defense Maaike Ferwerda On June 20, 2018 Maaike Ferwerda will defend her dissertation about the development and effectiveness of a tailored guided internet-based cognitive behavioural therapy.